Results 131 to 140 of about 13,851 (214)

Stage-Dependent Peri-Implant Bone Remodelling Under Occlusal Contact in a Murine Model. [PDF]

Int Dent J
Cao R, Takemura Y, Moriyama Y, Lai W, Chen X, Izumi A, Abe M, Ayukawa Y.   +7 more
europepmc   +1 more source

Sclerostin as a Putative Myokine in Sarcopenia

Endocrinology and Metabolism, 2022
openaire   +3 more sources

Novel bioactive compounds in the treatment of osteoporosis: chemistry-driven discovery from preclinical validation to clinical translation. [PDF]

Front Chem
Fan H, Jin S.
europepmc   +1 more source

Future directions of osteoanabolic therapies in osteoporosis: Integrating current anabolic agents and emerging senescence-targeted strategies. [PDF]

Best Pract Res Clin Rheumatol
Brooks HW, Cusick NC, Wu S, Farr JN.
europepmc   +1 more source

Sclerostin Measurement [PDF]

, 2020
openaire   +1 more source

Correlation analysis of serum CCL3, TRACP-5b, and sclerostin with the prognosis of multiple myeloma patients. [PDF]

J Med Biochem
Jiang C, Sun M, Gao D, Zhang X, Pan J.
europepmc   +1 more source

Irisin treatment counteracts bone loss and muscle atrophy in aged mice by reducing sclerostin expression in bone and skeletal muscle. [PDF]

J Transl Med
Suriano C, Zerlotin R, Taurino M, Dicarlo M, Storlino G, Pignataro P, Terrevoli OD, Pellicani L, Oranger A, Mori G, Passeri G, Colucci SC, Colaianni G, Grano M.   +13 more
europepmc   +1 more source

Efficacy of romosozumab as sequential therapy for bisphosphonates in glucocorticoid-induced osteoporosis. [PDF]

JBMR Plus
Kawazoe M, Muraoka S, Yamada Z, Hirose W, Watanabe E, Nishio J, Nanki T.   +6 more
europepmc   +1 more source

<i>Sost</i> deficiency leads to greater bone vascular porosity, but similar osteocyte lacunar properties with increasing age. [PDF]

Bone Rep
deVet T, Helou A, Checa S, Rack A, Kramer I, Wilde F, Zaslansky P, Willie BM.   +7 more
europepmc   +1 more source

Urinary Sclerostin and Renal Magnesium Handling in Proteinuric Nondiabetic Chronic Kidney Disease.

Kidney Blood Press Res
Wu CF, Kuo TH, Wu AB, Lin WH, Chao JY, Hung SY, Tseng CC, Liou HH, Wang MC.   +8 more
europepmc   +1 more source